Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatic Denervation and Glucose Metabolism in Liver Transplant Recipients
NCT03685773Phase 2Withdrawn
- Sponsor
- Albert Einstein College of Medicine
- Start
- Apr 2019
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diazoxide in type 2 diabetes mellitus (T2DM), sponsored by Albert Einstein College of Medicine. Planned start Apr 2019; status: withdrawn.
02
Drugs
diazoxide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03685773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03685773.